Phibro Animal Health Appoints Joyce J. Lee to Strengthen Board Leadership

Phibro Animal Health Expands Board with Strategic Appointment

Phibro Animal Health Corporation (Nasdaq: PAHC) strengthens its leadership team with the appointment of Joyce J. Lee as a Class II independent director. This decision, effective immediately, fills a vacancy on the board and increases its membership to nine, with six independent directors now serving. Ms. Lee brings a wealth of experience from her notable tenure as President of Cobb Vantress LLC, where she championed responsible genetic innovation in the animal health sector. Her leadership history includes key roles at major companies like Elanco, Bayer Animal Health, and Zoetis, providing her with a comprehensive understanding of the industry's diverse needs.

Ms. Lee's extensive career spans various functions critical to animal health, including global genetics production, general management, strategy, and marketing. This multifaceted background equips her to contribute significantly to Phibro's strategic vision and operational goals. Her previous recognition, including the Feather in Her Cap Award in 2018, underscores her impactful contributions to the field. Notably, her experience on corporate governance and audit committees at publicly traded companies further enriches her capability to navigate complex corporate landscapes, thereby enhancing Phibro's board's effectiveness.

Jack Bendheim, Phibro's Chairman, President, and CEO, expresses strong support for Ms. Lee's appointment, citing her strategic insights and operational expertise as invaluable assets. Her familiarity with leading brands across various segments, including beef, dairy, swine, and global aquaculture, positions her well to help Phibro achieve its mission of being a trusted partner for livestock producers, farmers, veterinarians, and consumers. This appointment signifies Phibro's commitment to strengthening its governance and operational capabilities as it seeks to enhance the health of both farm and companion animals.

In other relevant news, Phibro Animal Health continues to focus on developing innovative solutions that promote animal welfare and improve productivity within the agricultural sector. The company remains dedicated to its goal of offering reliable products that meet the evolving needs of the industry, cementing its position as a key player in the global animal health market. For more information about Phibro's initiatives and offerings, visit their website at www.pahc.com.